Up-Regulation of A-Type Potassium Currents Protects Neurons Against Cerebral Ischemia

Transient Forebrain Ischemia and Brain Slice Preparation

Transient forebrain ischemia was induced using the four-vessel occlusion method (Pulsinelli and Brierley, 1979) with modifications (Ren et al, 1997). The animals were anesthetized with a mixture of 1% to 2% halothane, 33% O₂, and 66% N₂. The common carotid arteries were isolated after which a silicon-tube loop was placed loosely around each common carotid artery to allow subsequent occlusion of these vessels. The vertebral arteries were electrocauterized. A temperature probe (0.025“ OD; Physitemp, Clifton, NJ, USA) was inserted beneath the skull in the extradural space, and the brain temperature was maintained at 37°C. Glass microelectrodes filled with 2 mol/L NaCl were used to record ischemic depolarization. The microelectrode was advanced 3.0 mm below dura into the neostriatum. The recordings were performed with an amplifier (Neuroprobe, Model 1600; A-M Systems, Carlsborg, WA, USA). The duration of ischemic depolarization was determined by measuring the period from the beginning of the extracellular direct current potential reaching −20 mV to the point where the potential started to repolarize after recirculation. Transient forebrain ischemia was produced by occluding both common carotid arteries to induce ischemic depolarization for ∼22 minutes. Cerebral blood flow resumed immediately upon release of the carotid artery clasps.

Brain slices were prepared from animals before ischemia and at different interval after reperfusion using procedures similar to those previously described (Pang et al, 2002). Briefly, the animals were anesthetized with ketamine-HCl (80 mg/kg, intraperitoneally) and decapitated. The brains were quickly removed and immersed in ice-cold artificial cerebrospinal fluid, which was composed of the following (in mM): 130 NaCl, 3 KCl, 2 CaCl₂, 2 MgCl₂, 1.25 NaH₂PO₄, 26 NaHCO₃, and 10 glucose, pH 7.4, 295 to 305 mOsm/L. Transverse striatal slices of 300 μm thickness were cut using a vibratome (VT 1000; Leica, Nussloch, Germany) and incubated in artificial cerebrospinal fluid for ≥ 1 hour at room temperature (∼24°C) before being transferred to the recording chamber.

Cell Cultures

For neuronal culture, the striatum was dissected from E18 embryo in an ice-cold Hank's balanced salt solution without Ca²⁺ and Mg²⁺ (Invitrogen, Carlsbad, CA, USA) and incubated with 0.125% trypsin (Invitrogen) for 30 minutes at 37°C. Tissues were then triturated with fire-polished Pasteur pipettes (Fisher Scientific, Pittsburgh, PA, USA) and centrifuge at 1,000 for 10 minutes. Cells were resuspended in Neurobasal medium containing 2% B27 (Invitrogen) and plated on 24-well plates or 12 mm glass cover slips (Fisher Scientific) coated with 0.01% (w/v) poly-l-lysine (Sigma, St Louis, MO, USA) at a density of 2 × 10⁵ cells per well or per cover slip. Neurons were put into a standard incubator (Taibai Espec, Osaka, Japan) maintained at 37°C in 95% air, 5% CO₂. In some experiments, cortical neurons were cultured from 1-day-old Kv1.4^−/-/Kv4.2^−/- double KO and WT pups.

HEK293 cells were cultured in Dulbecco's Modified Eagle Media supplemented with 10% fetal bovine serum, 100 U/mL penicillin, and 100 μg/mL streptomycin (Invitrogen).

Transfection of Recombinant Kv Channels

The FuGENE6 transfection reagent (Roche Molecular Biochemicals, Indianapolis, IN, USA) was used for Kv channel transfection. Cultured neurons at 2 days in vitro (DIV) were transfected with pEGFP-N1, or a mixture of pEGFP-N1 and Kv constructs (1:1). To transfect one well of neurons in a 24-well plate, 1.5 μL FuGENE6 was diluted with 100 μL B27-free neurobasal media. After 5 minutes incubation at room temperature, 1 μg of plasmid DNA was added. The mixture was then added to the neuronal culture following 15 minutes incubation at room temperature.

Intrastriatal Delivery of Adeno-Associated Virus and Quantification of Neuronal Survival After Ischemia

To prepare AAV1-Kv4.2, the rat Kv4.2 cDMA was excised from rKv4.2-pcDNA3.1 and was used to replace green fluorescent protein (GFP) of pssAAV-GFP (Lowery et al, 2009) using a NheI/XbaI digestion to create pAAV-Kv4.2. Viral stocks of AAV-Kv4.2 (serotype 1) were prepared using the triple-transfection method and purified on a cesium chloride gradient by ultracentrifugation (Howard et al, 2008; Lowery et al, 2009).

Rats were anesthetized with 2% halothane and placed in a stereotaxic apparatus (KOPF, Tujunga, CA, USA). Intrastriatal (0.7 mm anterior to bregma, 3.0 mm lateral from the midline, and at a depth of 4.0 mm) infusion of adeno-associated virus (AAV) vectors (AAV1-GFP and AAV1-Kv4.2, 1.0 × 10¹¹ viral genomes/each AAV, 4 μL each) were performed at the rate of 0.5 μL/min over 10 minutes using a 30-gauge beveled needle. After infusion, the needle was left in place for 15 minutes. In both control and ischemic groups, GFP only or GFP + Kv4.2 was injected into the left or right striatum of the same animal to reduce the variability of sampling and ischemic insult. Thirteen days after AAV infusion, rats were subjected to 22 minutes transient forebrain ischemia followed by 24 hours reperfusion and fixed with 4% paraformaldehyde. Brains were cut into 40 μm serial coronal sections. A total of six sections (collected every fifth section) were obtained from each animal using injection needle track as a reference (three sections roastal and three sections causal to the track). GFP-positive neurons were distinguished from glial cells by their smooth somata and extensive dendritic branches. The GFP-positive neurons in the striatum of each section were counted under fluorescence microscope (X200, Olympus BX50; Olympus Optical, Tokyo, Japan) using double-blind methods. The numbers of GFP-positive neurons in the sections of each animal were summed and grouped into four groups: GFP control, GFP ischemia, GFP + Kv4.2 control, and GFP + Kv4.2 ischemia. The neuronal survival was presented as the percentage of GFP-positive neurons in ischemic animals against that in control ones in AAV1-GFP alone and AAV1-GFP plus AAV1-Kv4.2 groups respectively.

Oxygen/Glucose Deprivation and Cell Death Assay

Cultured neurons at DIV 10 were subjected to oxygen/glucose deprivation (OGD). Cultures were placed in an anaerobic chamber (ThermoForma, Marietta, OH, USA) and washed with deoxygenated, glucose-free balance salt solution containing (in mM): 116 NaCl, 5.4 KCl, 0.8 MgSO₄, 1.0 NaH₂PO₄, 26.2 NaHCO₃, 1.8 CaCl₂, bubbled with 95% N₂ and 5% CO₂ for 30 minutes. Then, cultures were aerated with an anaerobic gas mixture (5% CO₂, 10% H₂, and 85% N₂) at a constant pressure of 0.15 bars to remove residual oxygen. The anaerobic chamber was humidified and maintained at 37°C. Oxygen/glucose deprivation was terminated by replacing balance salt solution with normal culture medium and retained to the culture incubator. Control cultures were performed by exposing to balance salt solution containing 20 mmol/L d-glucose and maintained in the culture incubator.

The neuronal death after OGD was assessed using MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. After incubation with 100 μL MTT (5 mg/mL; Sigma) at 37°C for 5 hours, the media was removed, and 1 mL dimethyl sulfoxide (DMSO) was added into each well to dissolve crystals, of which 100 μL was added into 96-well plate to measure the absorbance at 550 nm using a plate reader (Expert 96UV, AsysHitech, Eugendorf, Austria).

The effects of transfection of recombinant Kv on neuronal viability were evaluated using methods for analysis of neuronal survival similar to those previously described (Mattson et al, 1995). Briefly, the number of GFP-positive intact neurons in the identical field (× 10 objective) was counted under fluorescent microscope at 24 hours before and 24 hours after 4 hours OGD. Most neurons that died during the time interval were absent. Remaining neurons with intact neurites and a soma with smooth round appearance were considered viable. Neurons with degenerating features (such as the vacuolated or swollen soma, beady dendrite, and fragmentation) were identified as nonviable. The value was compared between the cultures transfected with GFP plus recombinant Kv and those transfected with GFP alone.

Electrophysiological Recording

Recording electrodes were prepared from borosilicate glass (Warner Instruments, Hamden, CT, USA) using a horizontal electrode puller (P-97; Sutter Instruments, Novato, CA, USA). Electrodes were filled with an intracellular solution containing (in mmol/L): 145 KCl, 1 MgCl₂, 10 EGTA, 0.2 CaCl₂, 10 HEPES, 2 Na₂ATP, and 2% neurobiotin (Vector Laboratories, Burlingame, CA, USA), pH 7.4, 290 to 295 mOsm/L. For recording from brain slice, oxygenated artificial cerebrospinal fluid was used as extracellular solution. For recording on cultured neurons or HEK293 cells, the extracellular solution contained (in mM): 144 NaCl, 6 KCl, 1 MgCl₂, 1 CaCl₂, 10 HEPES, pH 7.3, 300 to 305 mOsm/L. The flow rate of extracellular solution was adjusted to 2 to 3 mL/min. Recordings were carried out at room temperature. Cells were visualized with an infrared-differential interference contrast or fluorescent microscope (BX50WI; Olympus Optical) and a CCD camera. Whole-cell patch-clamp recordings were performed with an Axopatch 200B amplifier (Axon Instruments, Foster City, CA, USA). After tight-seal (> 1 GΩ) formation, the electrode capacitance was compensated. Immediately after establishment of whole-cell configuration, the resting membrane potential was obtained by direct reading from the amplifier. The membrane capacitance, series resistance, and input resistance of the recorded neurons were measured by applying a 5-mV (10 milliseconds) hyperpolarizing voltage pulse from a holding potential of −60 mV The series resistance was 8 to 12 MΩ. Cells with a series resistance > 10% of the input resistance were discarded. The membrane capacitance reading was used as the value for whole-cell capacitance. During the experiment, the membrane capacitance and series resistance were periodically monitored. Cells with a series resistance change > 20% during the experiment were excluded from the analysis. Signals were filtered at 2 kHz and digitized at a sampling rate of 5 kHz using a data-acquisition program (Axograph 4.6; Axon Instruments).

At a holding potential of −60 mV, the voltage-dependent outward potassium currents were evoked by voltage steps (from −80 mV to +70 mV in 10 mV increments, 400 milliseconds) following a 300-millisecond hyperpolarizing pulse of −120 mV in the presence of tetrodotoxin (1 μM) and CdCl₂ (300 μM) to block voltage-activated Na⁺ and Ca²⁺ currents, as well as Ca²⁺-activated potassium currents. Taking advantage of the rapid inactivation at depolarized membrane potential, I_A was isolated by subtracting the currents evoked after depolarized prepulses (+ 10 mV, 100 mV) from those evoked without depolarized prepulses. In some experiments, 4-AP (4-aminopyridine; 10 mmol/L) and TEA (20 mmol/L) were applied to examine the pharmacological characteristics of I_A.

The current density of I_A for each neuron was obtained by dividing the membrane capacitance from current amplitude. The current amplitude of I_A was measured at the peak of each current (∼4 milliseconds after the onset of the command pulses). The steady-state activation curves were established similarly to those previously reported (Deng et al, 2004). Briefly, the conductance (G) was calculated using the following equation: G = I/(V_m–V_k), where I was the current amplitude, V_m was the command potential, and V_k was the reversal potential of potassium (V_k = −98 mV). The conductance was then normalized with respect to the maximum value and plotted as a function of the membrane potential during the test pulse. The resulting activation curves were fitted with a normalized Boltzmann distribution: G/G_max = 1/[1 + exp(V_m–V_1/2)/V_c], where G_max was the maximum conductance at + 70 mV, V_1/2 was the membrane voltage at which the current amplitude was half-maximum, and V_c was the slope factor at V_1/2. The steady-state inactivation properties of I_A were determined by measuring the current availability with a testing pulse of + 70 mV following 2 seconds prepulse between −120 mV and 0 mV The plot of mean normalized peak currents as a function of prepulse voltage was fitted with a normalized Boltzmann distribution: I/I_max = 1/[1 + exp(V_1/2–V_m)/V_c], where I_max was the maximum current at + 70 mV To study the removal of inactivation, I_A was inactivated by depolarizing to +70 mV for 100 milliseconds from a holding potential of −60 mV, and then inactivation was removed by hyperpolarizing to −120 mV for different periods of time before a test pulse of + 70 mV The plot of normalized peak currents as a function of hyperpolarization duration was fitted with a biexponential function.

In current-clamp recording, fast I-clamp mode was used. The first spike latency was measured from the onset of the current injection to the peak of the action potential evoked by a threshold current (100 milliseconds).

Drug Application

Phorbol-12,13-dibutyrate, chelerythrine, GF109203X, and 4α-phorbol were purchased from Sigma. Drugs were prepared as concentrated stocks and stored at −20°C. Working solutions were prepared immediately before use.

Immunohistochemistry

The following primary antibodies were used: mouse anti-protein kinase Cα (anti-PKCα) (1:50; Santa Cruz Biotechnology, Santa Cruz, CA, USA), mouse anti-PKCγ (1:500; Sigma), and rabbit anti-ChAT (anti-choline acetyltransferase) (1:250; Chemicon, Temecula, CA, USA). Animals were anesthetized and perfused through the ascending aorta with a solution of phosphate-buffered saline (PBS) (0.01 mol/L, pH 7.4) for ∼5 minutes, followed by 4% paraformaldehyde in PBS for 20 to 30 minutes. Brains were removed and postfixed in 4% paraformaldehyde at 4°C overnight. Coronal sections containing striatum were cut (50 μm) with a vibratome and collected in PBS. Sections were blocked with normal serum (10% in PBS containing 0.5% Triton X-100) for 2 hours at room temperature and incubated in a solution contaisning primary antibody of PKC isoform for 18 hours at 4°C. Then, sections were incubated in a solution containing fluorescein-conjugated secondary antibody (1:100; Vector Laboratories) for 2 hours at room temperature. After repeated washes in PBS, the stained sections were incubated with rabbit anti-ChAT at 4°C overnight, followed by rhodamine-conjugated secondary antibody (1:100; Vector Laboratories) for 4 hours at room temperature. The labeled neurons were examined with a microscope (BX50; Olympus Optical) equipped with reflected light fluorescence attachment (BX-FLA; Olympus Optical). Fluorescent images were acquired with a digital camera coupled to a software (DP70-BSW; Olympus Optical) at × 40 magnification. The settings were kept constant throughout all experiments.

Western Blotting

Brain tissues were lysed with ice-cold RIPA buffer (50 mmol/L Tris, pH 7.4, 150 mmol/L NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate; Boston BioProducts, Worcester, MA, USA) supplemented with a protease inhibitor cocktail (Roche) and incubated an additional 30 minutes on ice. After brief sonication on ice, cell lysates were centrifuged at 12,000 g for 20 minutes at 4°C to pellet nuclei and debris, and the resulting supernatants were collected for analysis. Protein concentration was determined by bicinchoninic acid (BCA) protein assay (Bio-Rad, Hercules, CA, USA). Protein samples were boiled in 2 × sodium dodecyl sulfate gel-loading buffer (Invitrogen) before sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Proteins (20 μg) were separated on 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels and transferred to nitrocellulose membranes (Millipore, Bedford, MA, USA). The membranes were rinsed with distilled water, blocked with 1% bovine serum albumin (Sigma) in Tris-buffer saline (TBS)-0.1% Tween 20 (TBS with 0.1% Tween 20) for 1 hour, and then incubated with primary antibodies overnight in blocking buffer at 4°C. We used rabbit polyclonal anti-Kv4.2 or Kv1.4 (1:1,000; Chemicon) or mouse monoclonal anti-β-actin antibodies (1:20,000; Sigma). The membranes were washed with TBST, and incubated at room temperature for 1 hour with horseradish peroxidase-conjugated anti-rabbit (1:5,000; Chemicon) or anti-mouse secondary antibodies (1:20,000; Chemicon). Bands were detected by the enhanced chemiluminescence (ECL; Amersham, Piscataway, NJ, USA) and visualized by exposing the membrane to X-ray films (Fuji, Tokyo, Japan).

Data Analysis

The values were presented as mean ± s.e.m. Unless stated otherwise, analysis of variance followed by post hoc Scheffe's test was used for statistical analysis (StatView 5.0; Abacus Concepts, Berkeley, CA, USA). Changes were considered significant if P < 0.05.

Increase of A-Type Potassium Current in Large Aspiny Neurons After Transient Forebrain Ischemia

Whole-cell patch-clamp recording was performed on visually identified MS and LA neurons in brain slices prepared before ischemia and at different intervals after reperfusion. Because MS neurons start to degenerate at 6 to 8 hours after transient forebrain ischemia and most of them die by 24 hours following reperfusion (Pulsinelli et al, 1982), we recorded I_A from MS neurons at 4 hours and 8 hours after ischemia. The changes of I_A in LA neurons were examined at 6 and 24 hours after ischemia, since these neurons are resistant to ischemic insults. Large aspiny neurons (> 20 μm in diameter) were distinguishable from MS neurons (10 to 20 μm) based on their somatic size and electrophysiological properties (Deng et al, 2007; Kawaguchi et al, 1995).

I_A was isolated using protocols as shown in Figure 1A. In LA neurons, the current density of I_A was significantly increased after ischemia (Figures 1B and 1C). At a depolarizing step of +30mV, the current density of I_A was 86.5 ± 4.7 pA/pF (n = 18) in control neurons and dramatically increased to 142.6 ± 6.2 pA/pF at 24 hours after ischemia (n = 14, P < 0.01). However, no significant change in I_A was detected in MS neurons after ischemia (Figure 1D). When evoked at + 30 mV, the current density of I_A in MS neurons was 93.3 ± 8.2 pA/pF (n = 15) in control, and 90.1 ± 10.7 pA/pF (n = 7) at 8 hours after ischemia. These data indicate that the current densities of I_A in LA neurons and MS neurons are similar in control animals, but are differentially altered after ischemia.

OPEN IN VIEWER

Figure 1

Increase of A-type potassium current (I_A) in large aspiny (LA) neurons after transient forebrain ischemia. (A) Representative recordings showing the isolation of I_A. (A1) Currents evoked by a series of depolarizing steps from −60 mV to +40 mV following a hyperpolarizing step of −120 mV. (A2) Currents evoked by the same voltage steps with a prepulse of +10 mV to inactivate I_A. (A3) The I_A was isolated by subtracting the currents from A1 by that from A2. (B) Representative traces of I_A recorded from control and ischemic LA neurons. (C) Pooled data showing the postischemic increase of the current density of I_A in LA neurons. (D) No significant change in the current density of I_A was detected in medium spiny (MS) neurons after ischemia. The inserts in (C, D) show the current densities of I_A evoked at +30 mV. (E) Decay time constants of I_A in LA neurons. (Upper panel) Representative fittings of the decay phase of I_A (evoked at +30 mV) with a biexponential function. (Lower panel) Both of the fast and slow decay time constant of I_A remained unchanged after ischemia. (F) Voltage dependence of the activation and inactivation of I_A in LA neurons. No significant change in activation curves was observed. However, the inactivation curve significantly shifted in a depolarizing direction after ischemia. The insert shows a representative recording of the steady-state inactivation of I_A and the protocol. (G) Removal of inactivation of I_A in LA neurons. The removal of inactivation curves were fitted with a biexponential function. While the slow component showed no significant change, the fast time constant was decreased after ischemia. The insert shows a representative recording and the protocol. *P < 0.01.

To further characterize the changes of I_A in LA neurons, the decay kinetics and the voltage dependence of activation and inactivation of I_A were investigated. The decay phase of I_A could be well fitted by a biexponential function, yielding fast and slow decay time constants (c). As shown in Figure 1E, neither τ_fast nor τ_slow displayed any significant change after ischemia. The voltage-dependent activation of I_A in control LA neurons was fitted by a single Boltzmann distribution with a V_1/2 of-24.5 ± 2.3 mV and a V_c of 14.7 ± 0.9 mV (n = 11). No significant changes in V_1/2 and V_c were detected 24 hours after ischemia (V_1/2: −23.1 ± 2.0 mV; V_c: 15.6 ± 0.6 mV; n = 11). For steady-state inactivation, the V_1/2 of the inactivation curve shifted significantly from −71.5 ± 3.4 mV (n = 11) of control to −57.5 ± 1.1 mV (n = 10, P < 0.01) at 24 hours after ischemia without obvious change in the V_c (Figure 1F). The removal of inactivation of I_A was also examined. In control LA neurons, the fast and slow time constants of the removal of inactivation were 18.5 ± 1.9 milliseconds and 458.3 ± 92.3 milliseconds (n = 7), respectively. Although the fast time constant was decreased 24 hours after ischemia (9.8 ± 1.4 milliseconds, n = 8, P < 0.01), the slow time constant remained at similar levels (444.3 ± 68.7 milliseconds, n = 8; Figure 1G). Hence, most of the biophysical features of I_A remain unchanged after ischemia.

Up-regulation of A-Type Potassium Current by Protein Kinase C in Large Aspiny Neurons After Ischemia

Previous studies have demonstrated that PKC modulates I_A in neurons (Yuan et al, 2002). To reveal the PKC effects on I_A, the I_A in LA neurons was compared before and after application of PKC activators or inhibitors into the bath solutions of brain slices. In control LA neurons, application of phorbol-12,13-dibutyrate (1 μmol/L), an activator of PKC, reduced the amplitude of I_A by 41.1% ± 5.9% (n = 9, P < 0.01). However, inhibition of PKC with chelerythrine (10 μmol/L, n = 7) or GF109203X (1 μmol/L, n = 6) had no effects on I_A (Figure 2A), which indicates that there is no tonic PKC regulation of I_A in control neurons. In contrast, application of phorbol-12,13-dibutyrate on LA neurons 24 hours after ischemia significantly enhanced I_A by 33.6% ± 3.7% (n = 6, P < 0.01). Furthermore, application of chelerythrine (n = 7) or GF109203X (n = 5) dramatically decreased I_A by 40.1% ± 3.2% and 38.0% ± 6.7%, respectively (P < 0.01; Figure 2A). Parallel studies on effects of cAMP-dependent protein kinase (PKA) and protein tyrosine kinase did not yield similar results (data not shown). These results indicate that PKC has a condition-specific up-regulation of I_A after ischemia. The up-regulation of I_A by PKC might have a role in the postischemic increase of I_A in LA neurons.

OPEN IN VIEWER

Figure 2

Protein kinase C (PKC) is involved in the up-regulation of A-type potassium current (I_A) after ischemia. (A) Application of PKC activator (phorbol-12,13-dibutyrate (PDBu)) inhibited the amplitude of I_A in control neurons but enhanced I_A after ischemia. PKC inhibitors, either chelerythrine or GF109203X, had no effect on I_A in control neurons but decreased I_A after ischemia. The inactive form of phorbol ester (4α-phorbol) had no effect on I_A. The currents were evoked at +30 mV. The amplitudes of currents recorded in the presence of PKC activator or inhibitor were normalized to those before application of these drugs, respectively. (B) Expression of PKCα in large aspiny (LA) neurons. LA neurons were identified using antibodies against choline acetyltransferase (ChAT) (red). PKCα immunoreactivity (green) was detected in both control and postischemic LA neurons. No immunoreactivity of PKCγ (green) was detected in LA neurons before and after ischemia. Scale bar: 20 μm. *P < 0.01.

To identify the PKC isoforms involved in the up-regulation of I_A, the expression of PKC isoforms in LA neurons was examined. Previous studies have shown that PKCα and PKCγ are expressed in striatal neurons (Yoshihara et al, 1991). Immunostaining showed that the PKCα mainly located in the perikarya of the control LA neurons (Deng et al, 2009). However, at 24 hours after ischemia, most of the PKCα was found in the plasma membrane, indicating the activation of PKC (Figure 2B). Immunoreactivity for PKCγ was not detectable in LA neurons (Figure 2B). These results suggest that activation of PKCα might be associated with the postischemic up-regulation of I_A in LA neurons.

Protection of Neurons Against Ischemic Insults by Enhancement of A-Type Potassium Current

If an increase of I_A is neuroprotective against ischemic challenge, overexpression of I_A may improve the survival of MS neurons. To test this hypothesis, we used primary neuronal cultures from striatum because they compose of >90% of MS neurons. Ischemia in vitro was mimicked by OGD for different durations in cultures at 10 DIV. Neuronal viability was evaluated at 24 hours after OGD using MTT assay. The extent of cell death was more severe with the increase of OGD duration (Figure 3A). Oxygen/glucose deprivation for 4 hours induced ∼50% of cell death (45.0% ± 1.9%, n = 6, P < 0.01), and was selected as the experimental paradigm in the following studies. To verify if the alteration of I_A in cultures after OGD is consistent with the in vivo results, the I_A in cultured neurons was compared before and after OGD. The I_A was increased in cultured LA neurons but remained unchanged in cultured MS neurons following OGD. The current density of I_A in LA neurons was 128.2 ± 8.1 pA/pF (n = 9, at +30 mV) in control and 201.7 ± 18.5 pA/pF (n = 11, P < 0.01) at 24 hours following 4 hours OGD (Figure 3B). However, no significant change of I_A was observed in MS neurons after OGD (135.8 ± 11.6 pA/pF of control versus 124.9 ± 9.7 pA/pF 24 hours after OGD; Figure 3C). These results are consistent with the above in vivo data. Kv1.4 and Kv4.2 encode A-type potassium channels and they express abundantly in the brain. Recombinant expression of either Kv1.4 or Kv4.2 allowed an increase of I_A by more than twofold in cultured neurons (Figure 4A). Recombinant Kv has no significant effect on resting membrane potentials (control: −63.6 ± 1.3 mV, n = 13; Kv1.4: −64.6 ± 1.6 mV, n = 5; Kv4.2: −60.8 ± 1.9 mV, n = 6). To compare the membrane excitability of control and transfected neurons, the response to a threshold depolarizing current was examined with the holding potential maintained at around −90 mV. Compared with that of control neurons (118.2 ± 12.9 pA, n = 13), the threshold current for evoking first spike was significantly increased in neurons transfected with Kv1.4 (185.6 ± 22.1 pA, n = 5, P < 0.01) or Kv4.2 (185.3 ± 17.3 pA, n = 6, P < 0.01). Consistently, the input resistance was dramatically decreased in neurons transfected with Kv channels (control: 459.8 ± 62.4 MΩ, n = 13; Kv1.4: 275.4 ± 30.3 MΩ, n = 5; Kv4.2: 261.4 ± 27.9 MΩ, n = 6; P < 0.05). In addition, the half-width of action potential was significantly reduced from 1.12 ± 0.05 milliseconds of control (n = 13) to 0.73 ± 0.04 milliseconds of Kv1.4 (n = 5, P < 0.01) and 0.69 ± 0.04 milliseconds Kv4.2 (n = 6, P < 0.01). Moreover, the increase of I_A by either Kv1.4 or Kv4.2 resulted in nearly doubling of first firing latency (Figure 4B). These results indicate that the membrane excitability in neurons infected with recombinant Kv is significantly decreased.

OPEN IN VIEWER

Figure 3

Differential changes of A-type potassium current (I_A) in cultured striatal neurons after oxygen/glucose deprivation (OGD). The large aspiny (LA) neurons in culture were identified based on their large cell bodies (> 30 μm) as compared with the medium spiny (MS) neurons (10 to 20 μm). (A) Effects of OGD on neuronal viability. (Upper panel) Representative photomicrographs showing the neuronal damage 24 hours after 4 hours OGD. Scale bar: 20 μm. (Lower panel) Pooled data showing the neuronal viability at 24 hours after OGD of different durations. The neuronal damage was significantly increased with increasing duration of OGD (n = 12 per group). The neuronal viability was evaluated using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. (B) Increase of I_A in cultured LA neurons after OGD. (Upper panel) Representative traces of I_A recorded before and 24 hours after 4 hours OGD. (Lower panel) Pooled data showing the significant increase of current density of I_A after OGD. (C) The current density of I_A in cultured MS neurons remained about the same after OGD. (Upper panel) Representative traces of I_A before and 24 hours after 4 hours OGD. (Lower panel) Pooled data showing that no significant change in the current density of I_A was observed after OGD. *P < 0.01.

OPEN IN VIEWER

Figure 4

Up-regulation of A-type potassium current (I_A) protects striatal neurons from ischemic insults. (A) The I_A is enhanced in neurons transfected with Kv1.4 or Kv4.2 channels. (Upper panel) Representative traces of I_A evoked at +30 mV in striatal neurons transfected with green fluorescent protein (GFP), Kv1.4 or Kv4.2 channel, respectively. (Lower panel) Temporal changes of I_A in striatal neurons after transfection. At 8 days after transfection (10 days in vitro (DIV)), the current density of I_A in neurons transfected with GFP alone was 81.8 ± 16.2 pA/pF (n = 6), and was 178.8 ± 8.1 pA/pF (n = 8, P < 0.01) and 212.9 ± 4.6 pA/pF (n = 7, P < 0.01) in neurons transfected with Kv1.4 or Kv4.2, respectively. (B) Transfection with Kv1.4 or Kv4.2 channels decreased the neuronal excitability. Neurons with recombinant Kv had a significantly longer latency to the first spike than the control ones (control: 56.5 ± 8.3 milliseconds, n = 13; Kv1.4: 94.8 ± 1.3 milliseconds, n = 5, P < 0.01; Kv4.2: 91.7 ± 2.9 milliseconds, n = 6, P < 0.01). These changes were completely reversed by application of 10 mmol/L 4-aminopyridine (4-AP) (n = 4 in each group, P < 0.01). (C) Representative photomicrographs showing neurons transfected with GFP alone before (C1) and after oxygen/glucose deprivation (OGD) (C2), and neurons transfected with Kv1.4 plus Kv4.2 channels before (C3) and after OGD (C4) in an identical field. Neurons transfected GFP alone died after OGD, resulting in fragments in the same location (C2), whereas most of the neurons transfected with GFP plus Kv1.4 and Kv4.2 remained intact (arrows, C4). (D) In comparison to neurons transfected with GFP alone, the cell viability after 4 hours OGD was significantly increased in neurons transfected with Kv1.4 or Kv4.2 channels. Cotransfection of Kv1.4 and Kv4.2 channels further increased the neuronal survival after OGD. (E) Application of I_A channel blocker 4-AP, but not other potassium channel blocker tetraethylammonium (TEA) (5 mmol/L), into the medium increased neuronal death after 4 hours OGD in a dose-dependent manner. ^†P < 0.05, *P < 0.01. Kv, voltage-dependent potassium current.

The neuronal viability after OGD was compared between the control cultures transfected with GFP alone and the cultures transfected with recombinant Kv (plus GFP) by counting the number of intact eurons in the identical fields at 24 hours before and 24 hours after 4 hours OGD (Figure 4C). Compared with the control cultures, the percentage of cell survival following OGD was significantly increased from 50% ± 2.16% (n = 59 wells) to 57.6% ± 2.4% (n = 59 wells, P < 0.05) or 61.4% ± 3.8% (n = 31 wells, P < 0.05) when transfected with Kv1.4 or Kv4.2, respectively (Figure 4D). Cotransfection of Kv1.4 and Kv4.2 further increased the viability to 84.1% ± 5.3% (n = 33 wells, P < 0.01) after OGD. In contrast, application of 4-AP at concentrations that block the I_A during OGD led to an increase of neuronal death in a dose-dependent manner (Figure 4E). In neurons treated with 5 mmol/L 4-AP, 4 hours OGD induced 91.6% ± 1.5% of cell death, which was significantly greater than that of control neurons (56.4% ± 4.3%, n = 9, P < 0.01). Moreover, application of 5 mmol/L TEA had no significant effect on the cell death after 4 hours OGD (53.3% ± 3.9%, n = 8; Figure 4E), indicating that 4-AP-sensitive I_A, rather than other potassium currents, has neuroprotective effects. These data demonstrate that the increase of I_A in MS neurons by recombinant expression of Kv1.4 or Kv4.2 channels conferred an increased resistance against ischemic insult.

Increased Neuronal Damage in Neurons Lacking Kv1.4 and Kv4.2

We further tested the roles of I_A in ischemic neuronal death in another ischemia-vulnerable brain region, cerebral cortex, using double KO mice lacking Kv1.4 and Kv4.2. Cortical neurons express prominent I_A mediated largely by Kv1.4, Kv4.2, and Kv4.3 (Norris and Nerbonne, 2010). Recordings from cultured cortical neuron revealed that the amplitude of I_A in neurons obtained from mice lacking Kv1.4 and Kv4.2 subunits was significantly reduced, compared with that of WT mice. When evoked at a voltage of +30mV, the I_A amplitudes were 1.77 ± 0.14 nA (n = 7) and 0.95 ± 0.08 nA (n = 8) in neurons from WT and double KO mice, respectively (P < 0.01; Figures 5A and 5B). Moreover, neurons lacking Kv1.4 and Kv4.2 exhibited a much higher sensitivity to ischemic insults. The cell survival at 24 hours after OGD (4 hours) was 52.6% ± 3.3% in WT neurons, and 17.9% ± 5.3% in double KO neurons (n = 10 in each group, P < 0.01; Figure 5C). These findings indicate that I_A has an important role in neuronal protection after cerebral ischemia, and that the neuroprotective roles of I_A is not only restricted in the striatum.

OPEN IN VIEWER

Figure 5

Double knockout (KO) of Kv1.4 and Kv4.2 increases neuronal vulnerability to oxygen/glucose deprivation (OGD). (A) Genotyping of KO mice. PCR genotyping of genomic mouse tail DNA samples was shown in (A1). The primers amplify a 783-bp fragment from the Kv1.4 locus and a 712-bp fragment from the Kv4.2 locus. (A2) Western blotting confirmed the absence of Kv1.4 protein (Mr ∼ 95 kDa) in the brain extracts of Kv1.4^−/- and double KO mice, and the absence of Kv4.2 protein (Mr ∼ 75 kDa) in the brain extracts of Kv4.2^−/- and double KO mice. β-Actin is used as a protein loading control. (B) Decreased A-type potassium current (I_A) in cortical neurons lacking both Kv1.4 and Kv4.2. Traces were evoked with voltages from −30 mV to 50 mV (in 20 mV increments). (B1) Representative recording traces. (B2) Grouped data of I_A amplitude. (C) Cortical neurons cultured from double KO mice exhibited an increased cell death 24 hours after OGD (4 hours). (C1) Photomicrographs showing the culture neurons from wild-type (WT) and double KO mice in control and 4 hours OGD-treated group. (C2) Histogram showing the neuronal viability significantly reduced in culture neurons from double KO mice after OGD. Scale bar: 50 μm. *P < 0.01. Kv, voltage-dependent potassium current.

Neuroprotective Roles of A-Type Potassium Current Against Ischemia In Vivo

The protective effects of I_A in striatal neurons were further examined using in vivo preparation. A-type potassium current was up-regulated in striatal neurons by overexpression of Kv4.2 subunit with AAV1-Kv4.2. To visualize the infected neurons, AAV1-GFP was also delivered together with AAV1-Kv4.2. We first examined the efficacy of AAV1-Kv4.2 infection. As shown in Figures 6A and 6B, the HEK cells that have little endogenous potassium current were infected with AAV1-GFP plus AAV1-Kv4.2. The amplitude of I_A in GFP-positive cells (3.28 ± 1.12 nA, n = 3) was significantly increased as compared with that of GFP-negative cells (0.41 ± 0.15 nA, n = 3, P < 0.01; Figures 6C and 6D). To obtain the optimal experimental conditions in vivo, different dosages of AAV1-GFP were delivered into the striatum and the animals survived for different durations. Based on these preliminary studies (data not shown), 8 μL AAV1-GFP and survival time of 14 days were chosen as our experimental paradigms. AAV1-GFP (4 μL) plus AAV1-Kv4.2 (4 μL) were delivered into the right side of the striatum. For comparison, AAV1-GFP alone was delivered into the left side of the striatum of the same animal. The animals were then subjected to transient forebrain ischemia 13 days after infection, and GFP-positive neurons were counted 24 hours after reperfusion. As shown in Figure 6, the neuronal viability was significantly increased in neurons infected with Kv4.2 (neuronal survival in AAV1-GFP group: 26.9% ± 3.8%; neuronal survival in AAV1-GFP plus AAV1-Kv4.2 group: 40.5% ± 9.1%; P < 0.01, χ² test; n = 8 to 12 animals in each group). The above results indicate that overexpression of I_A protects striatal neurons against ischemic insults in vivo.

OPEN IN VIEWER

Figure 6

Increased neuronal viability in Kv4.2-transfected striatal neurons after transient forebrain ischemia. (A, B) Photomicrographs of the HEK cells in the same area under bright field (A) and florescence microscope (B), showing the green fluorescent protein (GFP)-positive and -negative cells 1 day after infection of Kv4.2 and GFP. (C) Representative traces showing the A-type potassium current (I_A) recorded from GFP-negative (Control) and GFP-positive cells (Kv4.2 infected). (D) Pool data indicated that the I_A was significantly increased in cells coinfected with AAV1-Kv4.2 and AAV1-GFP. (E) Representative photomicrographs showing striatal neurons infected with AAV1-GFP or AAV1-GFP plus AAV1-Kv4.2 with or without ischemia. Scale bar: 100 μm. (F) Pooled data showing the number of GFP-positive neurons in the striatum significantly increase in animals infected with AAV1-GFP plus AAV1-Kv4.2 at 24 hours after ischemia. *P < 0.01. AAV, adeno-associated virus, Kv, voltage-dependent potassium current.